These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079 [TBL] [Abstract][Full Text] [Related]
3. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease. Schroeder A; Fahrenholz F; Schmitt U J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420 [TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP. Corbett GT; Gonzalez FJ; Pahan K Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426 [TBL] [Abstract][Full Text] [Related]
5. Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP. Zhang J; Jiang Y; Dong X; Meng Z; Ji L; Kang Y; Liu M; Zhou W; Song W Alzheimers Res Ther; 2024 Jul; 16(1):160. PubMed ID: 39030577 [TBL] [Abstract][Full Text] [Related]
6. ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function. Suh J; Choi SH; Romano DM; Gannon MA; Lesinski AN; Kim DY; Tanzi RE Neuron; 2013 Oct; 80(2):385-401. PubMed ID: 24055016 [TBL] [Abstract][Full Text] [Related]
7. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. Postina R; Schroeder A; Dewachter I; Bohl J; Schmitt U; Kojro E; Prinzen C; Endres K; Hiemke C; Blessing M; Flamez P; Dequenne A; Godaux E; van Leuven F; Fahrenholz F J Clin Invest; 2004 May; 113(10):1456-64. PubMed ID: 15146243 [TBL] [Abstract][Full Text] [Related]
8. Over-expression of two different forms of the alpha-secretase ADAM10 affects learning and memory in mice. Schmitt U; Hiemke C; Fahrenholz F; Schroeder A Behav Brain Res; 2006 Dec; 175(2):278-84. PubMed ID: 17014917 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus. Del Turco D; Schlaudraff J; Bonin M; Deller T PLoS One; 2014; 9(1):e84962. PubMed ID: 24404197 [TBL] [Abstract][Full Text] [Related]
10. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480 [TBL] [Abstract][Full Text] [Related]
11. Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5'-untranslated region. Lammich S; Buell D; Zilow S; Ludwig AK; Nuscher B; Lichtenthaler SF; Prinzen C; Fahrenholz F; Haass C J Biol Chem; 2010 May; 285(21):15753-60. PubMed ID: 20348102 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10). Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882 [TBL] [Abstract][Full Text] [Related]
13. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein. Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin. Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697 [TBL] [Abstract][Full Text] [Related]